cagrilintide fda 10mg Long-Acting Amylin Analog Cagrilintide 5mg Peptide | Puratek

Cao, J., Belousoff, M

It does not show that cagrilintide is approved, prescribable, or safe long-term it remains investigational, and a pending regulatory submission is not an approval

Below that shared effect, the molecular stories diverge completely

Tirzepatide is an FDA-approved drug with completed Phase 3 obesity trials, while cagrilintide is investigational, with monotherapy data only through Phase 2 and its strongest results coming from the CagriSema combination

Because research-market material is sold outside any approved supply chain, its identity and purity are unverified: published trial data describe a characterized study drug, not the contents of an arbitrary vial, so identity confirmation (for example by mass spectrometry and HPLC) and a batch certificate of analysis are the minimum a rigorous research setting should require

Safety is not symmetric